Hillstream BioPharma (HILS) Competitors $2.56 -0.05 (-1.92%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends HILS vs. NBTX, GLSI, VSTM, LFVN, ACTU, FULC, GALT, NKTX, SCPH, and OGIShould you be buying Hillstream BioPharma stock or one of its competitors? The main competitors of Hillstream BioPharma include Nanobiotix (NBTX), Greenwich LifeSciences (GLSI), Verastem (VSTM), LifeVantage (LFVN), Actuate Therapeutics (ACTU), Fulcrum Therapeutics (FULC), Galectin Therapeutics (GALT), Nkarta (NKTX), scPharmaceuticals (SCPH), and Organigram (OGI). These companies are all part of the "pharmaceutical preparations" industry. Hillstream BioPharma vs. Nanobiotix Greenwich LifeSciences Verastem LifeVantage Actuate Therapeutics Fulcrum Therapeutics Galectin Therapeutics Nkarta scPharmaceuticals Organigram Nanobiotix (NASDAQ:NBTX) and Hillstream BioPharma (NASDAQ:HILS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Which has better valuation & earnings, NBTX or HILS? Hillstream BioPharma has lower revenue, but higher earnings than Nanobiotix. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNanobiotix$39.18M4.56-$42.97MN/AN/AHillstream BioPharmaN/AN/A-$8.47M-$0.72-3.56 Does the MarketBeat Community believe in NBTX or HILS? Nanobiotix received 10 more outperform votes than Hillstream BioPharma when rated by MarketBeat users. Likewise, 64.71% of users gave Nanobiotix an outperform vote while only 50.00% of users gave Hillstream BioPharma an outperform vote. CompanyUnderperformOutperformNanobiotixOutperform Votes1164.71% Underperform Votes635.29% Hillstream BioPharmaOutperform Votes150.00% Underperform Votes150.00% Does the media refer more to NBTX or HILS? In the previous week, Hillstream BioPharma had 1 more articles in the media than Nanobiotix. MarketBeat recorded 1 mentions for Hillstream BioPharma and 0 mentions for Nanobiotix. Nanobiotix's average media sentiment score of 0.00 equaled Hillstream BioPharma'saverage media sentiment score. Company Overall Sentiment Nanobiotix Neutral Hillstream BioPharma Neutral Do insiders & institutionals believe in NBTX or HILS? 38.8% of Nanobiotix shares are owned by institutional investors. Comparatively, 13.4% of Hillstream BioPharma shares are owned by institutional investors. 3.5% of Nanobiotix shares are owned by insiders. Comparatively, 30.2% of Hillstream BioPharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk & volatility, NBTX or HILS? Nanobiotix has a beta of 0.33, suggesting that its share price is 67% less volatile than the S&P 500. Comparatively, Hillstream BioPharma has a beta of 3.08, suggesting that its share price is 208% more volatile than the S&P 500. Is NBTX or HILS more profitable? Nanobiotix's return on equity of 0.00% beat Hillstream BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets NanobiotixN/A N/A N/A Hillstream BioPharma N/A -188.44%-149.61% Do analysts rate NBTX or HILS? Nanobiotix presently has a consensus price target of $11.50, indicating a potential upside of 203.56%. Given Nanobiotix's stronger consensus rating and higher possible upside, equities analysts plainly believe Nanobiotix is more favorable than Hillstream BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanobiotix 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Hillstream BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNanobiotix beats Hillstream BioPharma on 9 of the 13 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Hillstream BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HILS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HILS vs. The Competition Export to ExcelMetricHillstream BioPharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$45.06M$6.59B$5.20B$8.85BDividend YieldN/A8.14%5.53%4.08%P/E Ratio-3.566.1277.9314.95Price / SalesN/A357.041,246.7687.31Price / CashN/A53.8240.9036.92Price / Book5.3310.617.196.55Net Income-$8.47M$153.27M$119.54M$226.22M7 Day Performance17.97%3.97%2.12%3.77%1 Month Performance19.63%-6.72%-2.43%4.64%1 Year PerformanceN/A33.26%34.52%29.21% Hillstream BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HILSHillstream BioPharmaN/A$2.56-1.9%N/AN/A$45.06MN/A-3.561News CoverageGap UpNBTXNanobiotix1.9892 of 5 stars$3.79-1.0%$11.50+203.6%-34.0%$178.55M$39.18M0.00100Gap DownGLSIGreenwich LifeSciences1.7488 of 5 stars$13.55+4.5%$38.00+180.4%+19.4%$178.18MN/A0.003News CoverageVSTMVerastem2.9096 of 5 stars$4.00+1.8%$12.50+212.5%-37.8%$178.04M$2.60M0.0050Analyst DowngradeAnalyst RevisionNews CoverageLFVNLifeVantage2.8357 of 5 stars$14.20+7.9%N/A+157.7%$177.78M$200.16M44.38260ACTUActuate TherapeuticsN/A$8.98-0.2%N/AN/A$175.38MN/A0.0010Gap UpFULCFulcrum Therapeutics3.6078 of 5 stars$3.25+9.4%$9.33+187.2%-28.6%$175.31M$2.81M0.00100GALTGalectin Therapeutics1.5372 of 5 stars$2.78+2.2%$11.00+295.7%+36.9%$174.47MN/A0.009Analyst UpgradeNKTXNkarta3.3284 of 5 stars$2.45+0.4%$15.00+512.2%-5.4%$172.90MN/A0.00140Analyst ForecastNews CoverageSCPHscPharmaceuticals3.8294 of 5 stars$3.35-3.2%$15.00+347.8%-39.0%$167.63M$13.59M-1.7630OGIOrganigram0.4621 of 5 stars$1.52+0.7%N/A+20.6%$165.56M$120.01M-3.62860 Related Companies and Tools Related Companies NBTX Competitors GLSI Competitors VSTM Competitors LFVN Competitors ACTU Competitors FULC Competitors GALT Competitors NKTX Competitors SCPH Competitors OGI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HILS) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hillstream BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hillstream BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
